Hokkaido University Collection of Scholarly and Academic Papers >
Global Institution for Collaborative Research and Education : GI-CoRE >
Peer-reviewed Journal Articles, etc >
Enhanced radiobiological effects at the distal end of a clinical proton beam : in vitro study
This item is licensed under:Creative Commons Attribution 4.0 International
Title: | Enhanced radiobiological effects at the distal end of a clinical proton beam : in vitro study |
Authors: | Matsumoto, Yoshitaka Browse this author | Matsuura, Taeko Browse this author →KAKEN DB | Wada, Mami Browse this author | Egashira, Yusuke Browse this author | Nishio, Teiji Browse this author | Furusawa, Yoshiya Browse this author |
Keywords: | proton beam | biological effectiveness | distal end | cell survival | spread-out Bragg-peak |
Issue Date: | 1-Jul-2014 |
Publisher: | Oxford University Press |
Journal Title: | Journal of Radiation Research |
Volume: | 55 |
Issue: | 4 |
Start Page: | 816 |
End Page: | 822 |
Publisher DOI: | 10.1093/jrr/rrt230 |
Abstract: | In the clinic, the relative biological effectiveness (RBE) value of 1.1 has usually been used in relation to the whole depth of the spread-out Bragg-peak (SOBP) of proton beams. The aim of this study was to confirm the actual biological effect in the SOBP at the very distal end of clinical proton beams using an in vitro cell system. A human salivary gland tumor cell line, HSG, was irradiated with clinical proton beams (accelerated by 190 MeV/u) and examined at different depths in the distal part and the center of the SOBP. Surviving fractions were analyzed with the colony formation assay. Cell survival curves and the survival parameters were obtained by fitting with the linear?quadratic (LQ) model. The RBE at each depth of the proton SOBP compared with that for X-rays was calculated by the biological equivalent dose, and the biological dose distribution was calculated from the RBE and the absorbed dose at each position. Although the physical dose distribution was flat in the SOBP, the RBE values calculated by the equivalent dose were significantly higher (up to 1.56 times) at the distal end than at the center of the SOBP. Additionally, the range of the isoeffective dose was extended beyond the range of the SOBP (up to 4.1 mm). From a clinical point of view, this may cause unexpected side effects to normal tissues at the distal position of the beam. It is important that the beam design and treatment planning take into consideration the biological dose distribution. |
Rights: | http://creativecommons.org/licenses/by/4.0/ |
Type: | article |
URI: | http://hdl.handle.net/2115/68331 |
Appears in Collections: | 国際連携研究教育局 : GI-CoRE (Global Institution for Collaborative Research and Education : GI-CoRE) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)
|
Submitter: 松浦 妙子
|